MiMedx Group, Inc.
MDXG
$6.68
$0.050.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 92.91M | 84.06M | 87.21M | 84.71M | 86.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 92.91M | 84.06M | 87.21M | 84.71M | 86.83M |
| Cost of Revenue | 16.91M | 15.32M | 14.86M | 12.99M | 13.84M |
| Gross Profit | 76.00M | 68.74M | 72.35M | 71.72M | 72.99M |
| SG&A Expenses | 61.09M | 54.17M | 45.70M | 55.44M | 54.88M |
| Depreciation & Amortization | 193.00K | 192.00K | 190.00K | 189.00K | 192.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.76M | 72.60M | 63.76M | 71.46M | 71.34M |
| Operating Income | 11.15M | 11.46M | 23.45M | 13.25M | 15.49M |
| Income Before Tax | 11.25M | 11.42M | 23.22M | 11.41M | 13.91M |
| Income Tax Expenses | 3.81M | 3.54M | 5.60M | 2.35M | -37.38M |
| Earnings from Continuing Operations | 7.44M | 7.88M | 17.62M | 9.06M | 51.29M |
| Earnings from Discontinued Operations | 0.00 | 217.00K | 4.00K | 200.00K | 2.19M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.44M | 8.10M | 17.63M | 9.26M | 53.48M |
| EBIT | 11.15M | 11.46M | 23.45M | 13.25M | 15.49M |
| EBITDA | 14.14M | 12.62M | 24.58M | 14.02M | 16.29M |
| EPS Basic | 0.05 | 0.06 | 0.12 | 0.06 | 0.39 |
| Normalized Basic EPS | 0.05 | 0.05 | 0.10 | 0.05 | 0.07 |
| EPS Diluted | 0.05 | 0.05 | 0.12 | 0.06 | 0.36 |
| Normalized Diluted EPS | 0.05 | 0.05 | 0.10 | 0.05 | 0.06 |
| Average Basic Shares Outstanding | 147.01M | 146.96M | 147.33M | 146.40M | 119.37M |
| Average Diluted Shares Outstanding | 149.24M | 148.37M | 148.90M | 150.03M | 148.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |